Sequel
Manchester, US · 5 known investors
Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.
Investors · 5
Competitors · 2
by search overlapTandem Diabetes Care, Inc.32 shared keywordsTandem Diabetes makes insulin pumps, including the Tandem Mobi and t:slim X2, powered by Control-IQ+ automated insulin delivery technology that adjusts insulin based on continuous glucose monitor readings. The devices serve people with type 1 and type 2 diabetes and integrate with mobile and cloud-based apps for diabetes management, primarily in the United States.
Diabetes25 shared keywordsThe American Diabetes Association is a nonprofit organization focused on diabetes prevention, research, advocacy, and education, providing resources, community programs, and support for people living with diabetes and prediabetes in the United States. It also advocates for policy such as affordable insulin and hosts scientific and technology conferences.
Companies competing with Sequel for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Sequel do?
- Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.
- Who are Sequel's investors?
- Sequel's investors include FemHealth Ventures, Graph Ventures, Javelin Venture Partners, Long Journey Ventures, Ulu Ventures.
- Where is Sequel headquartered?
- Sequel is headquartered in Manchester, US.